Literature DB >> 9233461

Receptive and expressive language function of children with symptomatic HIV infection and relationship with disease parameters: a longitudinal 24-month follow-up study.

P L Wolters1, P Brouwers, L Civitello, H A Moss.   

Abstract

OBJECTIVES: To longitudinally assess the receptive and expressive language functioning of children with symptomatic HIV disease and to explore the relationship between immune status, computed tomography (CT) brain scan abnormalities, and language dysfunction over time.
METHODS: Children with symptomatic HIV infection were administered an age-appropriate standardized comprehensive language test and general cognitive measure prior to starting antiretroviral therapy (n = 44) and again after 6 months (n = 29) and 24 months (n = 17). CD4 percentage and CT brain scans were also obtained at each evaluation.
RESULTS: Expressive language was significantly more impaired than receptive language at the baseline, 6- and 24-month evaluations. No significant changes over time were found in receptive or expressive language from baseline to after 6 months of antiretroviral therapy, but despite treatment, language scores declined significantly between 6 and 24 months. Overall cognitive function, however, remained stable from baseline to 24 months. Age-adjusted CD4 percentage increased significantly over the initial 6 months, then remained stable. Overall CT brain scan severity ratings did not change significantly over 24 months.
CONCLUSION: Expressive language was consistently more impaired than receptive language over 24 months, further supporting an earlier finding that expressive language was differentially affected by HIV in children with symptomatic disease. Both receptive and expressive language declined significantly after 24 months despite antiretroviral therapy, although overall cognitive function remained stable. Thus, functioning in some domains may be more vulnerable to the effects of HIV and global measures of cognitive ability may mask such differential changes in specific brain functions.

Entities:  

Mesh:

Year:  1997        PMID: 9233461     DOI: 10.1097/00002030-199709000-00009

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  22 in total

1.  Evidence for developmental dopaminergic alterations in the human immunodeficiency virus-1 transgenic rat.

Authors:  Katy M Webb; Michael Y Aksenov; Charles F Mactutus; Rosemarie M Booze
Journal:  J Neurovirol       Date:  2010-03       Impact factor: 2.643

2.  Brain and Cognitive Development Among U.S. Youth With Perinatally Acquired Human Immunodeficiency Virus Infection.

Authors:  Kathleen M Malee; Renee A Smith; Claude A Mellins
Journal:  J Pediatric Infect Dis Soc       Date:  2016-12       Impact factor: 3.164

3.  Cognitive, academic, and behavioral correlates of medication adherence in children and adolescents with perinatally acquired HIV infection.

Authors:  Sharon L Nichols; Grace Montepiedra; John J Farley; Patricia A Sirois; Kathleen Malee; Betsy Kammerer; Patricia A Garvie; Sylvie Naar-King
Journal:  J Dev Behav Pediatr       Date:  2012-05       Impact factor: 2.225

4.  Neurodevelopmental benefits of antiretroviral therapy in Ugandan children aged 0-6 years with HIV.

Authors:  Heena Brahmbhatt; Michael Boivin; Victor Ssempijja; Godfrey Kigozi; Joseph Kagaayi; David Serwadda; Ronald H Gray
Journal:  J Acquir Immune Defic Syndr       Date:  2014-11-01       Impact factor: 3.731

5.  Correlates of age at attainment of developmental milestones in HIV-infected infants receiving early antiretroviral therapy.

Authors:  Sarah Benki-Nugent; Christal Eshelman; Dalton Wamalwa; Agnes Langat; Ken Tapia; Helen Moraa Okinyi; Grace John-Stewart
Journal:  Pediatr Infect Dis J       Date:  2015-01       Impact factor: 2.129

Review 6.  Systematic review of neuroimaging studies in vertically transmitted HIV positive children and adolescents.

Authors:  Jacqueline Hoare; Gabrielle L Ransford; Nicole Phillips; Taryn Amos; Kirsten Donald; Dan J Stein
Journal:  Metab Brain Dis       Date:  2013-12-12       Impact factor: 3.584

7.  Longitudinal Evaluation of Language Impairment in Youth With Perinatally Acquired Human Immunodeficiency Virus (HIV) and Youth With Perinatal HIV Exposure.

Authors:  Sean M Redmond; Tzy-Jyun Yao; Jonathan S Russell; Mabel L Rice; Howard J Hoffman; George K Siberry; Toni Frederick; Murli Purswani; Paige L Williams
Journal:  J Pediatric Infect Dis Soc       Date:  2016-12       Impact factor: 3.164

8.  Improved Neurodevelopment After Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-infected Children.

Authors:  Laurén A Gómez; Claudia S Crowell; Irene Njuguna; Lisa M Cranmer; Dalton Wamalwa; Daisy Chebet; Vincent Otieno; Elizabeth Maleche-Obimbo; Melissa Gladstone; Grace John-Stewart; Sarah Benki-Nugent
Journal:  Pediatr Infect Dis J       Date:  2018-09       Impact factor: 2.129

9.  Neurodevelopmental trajectory of HIV-infected children accessing care in Kinshasa, Democratic Republic of Congo.

Authors:  Annelies Van Rie; Anna Dow; Aimee Mupuala; Paul Stewart
Journal:  J Acquir Immune Defic Syndr       Date:  2009-12       Impact factor: 3.731

Review 10.  Cognitive neuropsychology of HIV-associated neurocognitive disorders.

Authors:  Steven Paul Woods; David J Moore; Erica Weber; Igor Grant
Journal:  Neuropsychol Rev       Date:  2009-05-22       Impact factor: 7.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.